Involvement of oxygen-based radicals in methamphetamine-induced neurotoxicity: evidence from the use of CuZnSOD transgenic mice.
Cadet
J L
JL
Molecular Neuropsychiatry Section, NIH/NIDA, Baltimore, Maryland 21224.
Ali
S
S
Epstein
C
C
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D018698:Glutamic Acid / Q000378:metabolism; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D008694:Methamphetamine / Q000633:toxicity*; D051379:Mice; D008822:Mice, Transgenic; D009498:Neurotoxins / Q000633:toxicity*; D009569:Nitric Oxide / Q000378:metabolism*; D012701:Serotonin / Q000378:metabolism; D013482:Superoxide Dismutase / Q000235:genetics / Q000378:metabolism*; D013481:Superoxides / Q000378:metabolism*
D009498:Neurotoxins; D015102:3,4-Dihydroxyphenylacetic Acid; D013481:Superoxides; D009569:Nitric Oxide; D012701:Serotonin; D018698:Glutamic Acid; D008694:Methamphetamine; D006897:Hydroxyindoleacetic Acid; D013482:Superoxide Dismutase; D004298:Dopamine